Results 1 to 10 of about 2,230,889 (288)
Annals of Hepatology, 2003 Hepatorenal syndrome is complication of advanced cirrhosis characterized by renal failure, changes in systemic blood pressure, and increased activity of endogenous vasoactive systems.
Andrés Cárdenas, M.D. +1 more
doaj +8 more sources
BMC Gastroenterology, 2023 Background and aim In China, hepatorenal syndrome is a serious complication in the decompensated stage of hepatitis B cirrhosis, which requires early clinical intervention, so the early diagnosis of hepatorenal syndrome is crucial. This study establishes
Shouhao Wang +8 more
doaj +2 more sources
Hepatorenal Syndrome-Novel Insights into Diagnostics and Treatment. [PDF]
Int J Mol Sci, 2023 Hepatorenal syndrome (HRS) is a disorder associated with cirrhosis and renal impairment, with portal hypertension as its major underlying cause. Moreover, HRS is the third most common cause of acute kidney injury, thus creating a major public health ...
Badura K +6 more
europepmc +2 more sources
Role of renal Duplex ultrasonography in evaluation of hepatorenal syndrome
Egyptian Liver Journal, 2021 Background Hepatorenal syndrome is a potentially fatal complication of advanced liver disease. Markers for early diagnosis and identification of high-risk patients are lacking.
Mohamad Sherif Mogawer +6 more
doaj +2 more sources
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis [PDF]
, 2007 Hepatorenal syndrome (HRS) is a serious complication of end-stage liver disease, occurring mainly in patients with advanced cirrhosis and ascites, who have marked circulatory dysfunction,1 as well as in patients with acute liver failure.2 In spite of its
Francesco Salerno +4 more
openalex +7 more sources
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group [PDF]
Critical Care, 2012 IntroductionRenal dysfunction is a common complication in patients with end-stage cirrhosis. Since the original publication of the definition and diagnostic criteria for the hepatorenal syndrome (HRS), there have been major advances in our understanding ...
Mitra K. Nadim +8 more
openalex +2 more sources
Hepatorenal Syndrome: direct treatment costs and characteristics of patients admitted to intensive care [PDF]
Einstein (São Paulo)Objective The purpose of this study was to describe the direct medical costs incurred in Brazil for the treatment of Hepatorenal Syndrome in intensive care and intermediate therapy care units, and to investigate the impact of this syndrome on patient ...
Franciele Robes Hortelã +5 more
doaj +2 more sources
Frontiers in Pharmacology, 2021 Background: Terlipressin is the first-line pharmacological treatment for hepatorenal syndrome. When terlipressin is unavailable, midodrine/octreotide or norepinephrine, with albumin, represent the alternative treatments. The comparative efficacy of these
Eman Ibrahim El-Desoki Mahmoud +4 more
doaj +2 more sources
Low doses of terlipressin and albumin in the type I hepatorenal syndrome
Italian Journal of Medicine, 2013 BACKGROUND Hepatorenal syndrome is a pre-renal like dysfunction that generally onsets in cirrhotic patients presenting ascites. MATERIALS AND METHODS We investigated the improvement of renal function in subjects with hepatorenal syndrome after ...
Davide Pulvirenti, Aikaterini Tsami
doaj +3 more sources
Medicines, 2021 Background: This study aimed to determine the rates of inpatient palliative care service use and assess the impact of palliative care service use on in-hospital treatments and resource utilization in hospital admissions for hepatorenal syndrome. Methods:
Charat Thongprayoon +10 more
doaj +2 more sources